One of the key areas of interest for Ivermectin is its potential as an antiviral agent. Preclinical studies have suggested that Ivermectin has the ability to inhibit the replication of specific viruses, including those responsible for dengue fever, Zika virus, and West Nile virus. These findings have captured the attention of researchers, leading to the exploration of Ivermectin\s effectiveness against viral diseases such as COVID-19.